• 1
    Babjuk M, Oosterlinck W, Sylvester R et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update. Eur Urol 2011; 59: 9971008
  • 2
    Kirkali Z, Chan T, Manoharan M et al. Bladder cancer: epidemiology, staging and grading, and diagnosis. Urology 2005; 66: 434
  • 3
    Herr HW. The value of a second transurethral resection in evaluating patients with bladder tumors. J Urol 1999; 162: 7476
  • 4
    Dalbagni G, Vora K, Kaag M et al. Clinical outcome in a contemporary series of restaged patients with clinical T1 bladder cancer. Eur Urol 2009; 56: 903910
  • 5
    Herr HW, Donat SM, Dalbagni G. Can restaging transurethral resection of T1 bladder cancer select patients for immediate cystectomy? J Urol 2007; 177: 7579; discussion 9
  • 6
    Herr HW, Sogani PC. Does early cystectomy improve the survival of patients with high risk superficial bladder tumors? J Urol 2001; 166: 12961299
  • 7
    Chang SS, Cookson MS. Radical cystectomy for bladder cancer: the case for early intervention. Urol Clin North Am 2005; 32: 147155
  • 8
    Sengupta S, Blute ML. The management of superficial transitional cell carcinoma of the bladder. Urology 2006; 67: 4854; discussion -5
  • 9
    Kulkarni GS, Finelli A, Fleshner NE, Jewett MA, Lopushinsky SR, Alibhai SM. Optimal management of high-risk T1G3 bladder cancer: a decision analysis. Plos Med 2007; 4: e284
  • 10
    Thalmann GN, Markwalder R, Shahin O, Burkhard FC, Hochreiter WW, Studer UE. Primary T1G3 bladder cancer: organ preserving approach or immediate cystectomy? J Urol 2004; 172: 7075
  • 11
    Epstein JI, Amin MB, Reuter VR, Mostofi FK. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am J Surg Pathol 1998; 22: 14351448
  • 12
    Canter D, Egleston B, Wong YN et al. Use of radical cystectomy as initial therapy for the treatment of high-grade T1 urothelial carcinoma of the bladder: a SEER database analysis. Urol Oncol 2011; [Epub ahead of print] DOI:10.1016/j.urolonc.2011.07.009
  • 13
    Joudi FN, Smith BJ, O'Donnell MA, Konety BR. Contemporary management of superficial bladder cancer in the United States: a pattern of care analysis. Urology 2003; 62: 10831088
  • 14
    Ali-El-Dein B, Al-Marhoon MS, Abdel-Latif M et al. Survival after primary and deferred cystectomy for stage T1 transitional cell carcinoma of the bladder. Urol Ann 2011; 3: 127132
  • 15
    Gupta A, Lotan Y, Bastian PJ et al. Outcomes of patients with clinical T1 grade 3 urothelial cell bladder carcinoma treated with radical cystectomy. Urology 2008; 71: 302307
  • 16
    Huguet J, Crego M, Sabate S, Salvador J, Palou J, Villavicencio H. Cystectomy in patients with high risk superficial bladder tumors who fail intravesical BCG therapy: pre-cystectomy prostate involvement as a prognostic factor. Eur Urol 2005; 48: 5359; discussion 9
  • 17
    Guzzo TJ, Magheli A, Bivalacqua TJ et al. Pathological upstaging during radical cystectomy is associated with worse recurrence-free survival in patients with bacillus Calmette-Guerin-refractory bladder cancer. Urology 2009; 74: 12761280
  • 18
    Fritsche HM, Burger M, Svatek RS et al. Characteristics and outcomes of patients with clinical T1 grade 3 urothelial carcinoma treated with radical cystectomy: results from an international cohort. Eur Urol 2010; 57: 300309